M&A Explorer | A string of blockbuster deals reflect renewed market confidence and a favorable regulatory environment

M&A Explorer | Intense competition and shifting consumer habits are driving dealmaking across the sector

M&A Explorer | Public-to-private deal opportunities have provided US private equity firms with a reliable source of transaction flow in a volatile market, with the trend looking likely to continue

M&A Explorer | The string of megadeals announced in the first half of 2024 reflect a growing confidence among US dealmakers. But can the bull run be sustained?

M&A Explorer | Anticipated rate cuts spark investor optimism, but escalating geopolitical tensions threaten to derail economic recovery

M&A Explorer | Declining consumer spending power is driving down revenues and pushing luxury firms to seek new avenues for growth

M&A Explorer | Ongoing uncertainty hampers dealmaking in second quarter of the year, but mining megadeals and the race for clean energy offer a ray of hope

M&A Explorer | Against the odds, dealmakers put in a solid performance in 2022, but this year has seen a slow start as buyers in the US M&A market clamor for much needed regulatory clarity

M&A Explorer | M&A deal value falls by more than a third as dealmakers around the world hit the brakes in a volatile year

After peaking in 2021, the 2022 US M&A market was always going to seem slow by comparison—but what is likely to drive activity in the months ahead?

After a year of historic profits in 2021 following the mass roll-out of COVID-19 vaccines and related treatments, big pharma companies armed with cash for deals have been shifting their attention

M&A started strong in 2022 with robust deal activity and megadeals dominating the landscape that was largely the result of unprecedented spillover from 2021.

Despite a strong start to the year, deal activity in the US faced new challenges in 2022 as headwinds gathered.

M&A Explorer | Q3 dealmaking reflected multiple downward pressures on the market, including rising inflation, stock market volatility, and the spiralling European energy crisis

US deal activity saw an annual decrease in H1 of this year, but remains buoyant compared to pre-pandemic standards

Five factors that will shape dealmaking over the coming 12 months

Boosted by a few record-setting tech deals at the top end of the market, TMT continues to dominate US M&A value

Deal value in the first half of 2022 could not match the record-breaking level of activity in 2021

Dealmaking failed to reach the highs of the previous year as rising inflation and a challenging financing environment put some deals under question

While global dealmaking in Q1 was down from a blockbuster 2021, there are signs deal activity could pick up later in the year

Five factors that will shape dealmaking over the coming 12 months

In what was a stand-out year, M&A picked up the pace in almost every sector

All the stars aligned in 2021, creating a confident and exceptionally busy M&A market

Deal value exceeded US$1 trillion in every quarter for the first time in history, in just one example of the record-shattering 2021.  

Heightened interest in medical suppliers, contract research organizations and biotech firms resulted in an impressive year for healthcare dealmaking.

Despite a drop on the previous quarter, Q3 2021 global M&A value represented the strongest Q3 on Mergermarket record.